TrialWorld journal of urology2018

Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement.

Neal Shore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.